Tembhare PR, Sriram H, Khanka T, Gawai S, Bagal B, Ghogale SG, Deshpande N, Girase K, Patil J, Hasan SK et. al. Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant. Hemasphere. 2024 Apr 1;8(4):e63.

​

Mishra SV, Banerjee A, Sarkar D, Thangarathnam V, Bagal B, Hasan SK, Dutt S. DNA-PKcs mediated transcriptional regulation of TOP2β drives chemoresistance in acute myeloid leukemia. J Cell Sci 2024 Feb 1;137(3):jcs261931.

​

Gaur T, Ali A, Sharma D, Gupta SK, Gota V, Bagal B, Platzbeckar U, Mishra R, Dutt A, Khattry N, Mills K, Hassan Md., Sandur S, Hasan SK. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia. Cellular Signalling.  Cell Signal. 2024 Feb;114:111004.​

​​

Dutta RP, Kumar R, Tembhare PR, Bagal B, Swain RK, Hasan SK. Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins. Transl Oncol. 2023 Sep;35:101729.

​

Gokarn A, Tembhare PR, Hasan SK et. al. Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings. Transplant Cell Ther. 2023 Dec;29(12):777.e1-777.e8.(IF 3.6)

​

Kumar Gupta S, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kumar Kaushal R, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Hasan SK et. al. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. Int Immunopharmacology 2023 Aug; 121:110437.

​

Gaur T, Poddutoori R, Khare L, Bagal B, Rashmi S, Patkar N, Tembhare P, Pg S, Shetty D, Dutt A, Zhang Q, Konopleva M, Platzbeckar U, Gupta S, Samajdar S, Ramchandra M, Khattry N, Hasan SK. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax. J Exp Clin Cancer Res. 2023 Jul 29;42(1):186.

 

Sriram H, Kunjachan F, Khanka T, Gawai S, Ghogale S, Deshpande N, Girase K, Patil J, Chatterjee G, Rajpal S, Patkar NV, Bagal B, Jain H, Sengar M, Hasan SK, Khattry N, Subramanian PG, Gujral S, Tembhare PR.  Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent. Cytometry B Clin Cytom. 2022 Nov;102(6):462-470.

 

Sriram H, Khanka T, Kedia S, Tyagi P, Ghogale S, Deshpande N, Chatterjee G, Rajpal S, Patkar NV, Subramanian PG, Gujral S, Hasan SK, Tembhare PR. Improved protocol for plasma microRNA extraction and comparison of commercial kits. Biochem Med (Zagreb). 2021 Oct 15;31(3):030705.

 

Noguera NI*, Hasan SK*, Ammatuna E, Venditti A. Editorial: Metabolic Rewiring in Leukemias. Front Oncol. 2021 Oct 8;11:775167.* Joint corresponding author

 

Hasan SK, Patkar NV, Rajamanickam D, Gokarn A, Lucena-Araujo AR, Tembhare P, Bagal B, Kadam Amare P, Jain H, Gujral S, Sengar M, Subramanian PG, Khattry N. Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia. Hematol Oncol. 2020; 38(5):808-816

 

Gadewal N, Kumar R, Aher S, Gardane A, Gaur T, Varma AK, Khattry N, Hasan SK. miRNA-mRNA profiling reveals prognostic impact of SMC1A expression in acute myeloid leukemia. Oncol Res. 2020 May 29;28(3):321-330.

 

Bagal B, Kumar R, Gaur T, Talreja V, Bonda A, Patkar N, Shetty D, Kowtal P, Subramanian PG, Gupta S, Sarin R, Hasan SK. Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy. Med Oncol. 2020 Apr 10;37(5):48.

 

Kumar R, Kuligina E, Sokolenko A, Siddiqui Q, Gardi N, Gupta S, Varma AK, Hasan SK. Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling. Breast Cancer Res Treat. 2021 Jan;185(2):317-330.

 

Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni VI, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanović AM, Schürmann P, Prokofyeva DS, Bermisheva MA, Khusnutdinova EK, Bogdanova N, Dörk T, Imyanitov EN. Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39. Breast Cancer Res Treat. 2020 Feb;179(3):731-742.

 

Alfonso V, Iaccarino L, Ottone T, Cicconi L, Lavorgna S, Divona M, Cairoli R, Cristiano A, Ciardi C, Travaglini S, Falconi  G, Hasan SK et. al. Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia. Leukemia. 2019 Jun;33(6):1527-1530.

 

Patkar N, Kakirde C, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Deshpande N, Kadechkar S, Chatterjee G, Kannan S, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Bagal B, Menon H, Sengar M, Hasan SK et. al. Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World Context. Frontiers in Oncology 2019; Jun 13;9:450.

 

Patkar N, Shaikh AF, Kakirde C, Nathany S, Ramesh H, Bhanshe P, Joshi S, Chaudhary S, Kannan S, Hasan SK et. al. A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1. Blood Cancer Journal 2019; Oct 1;9(10):79

 

Iaccarino L, Ottone T, Hasan SK et. al. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis / relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia & Lymphoma 2018; 59(5):1268-1270

 

Ottone T, Alfonso V, Iaccarino L, Hasan SK et. al. Longitudinal detection of DNMT3A R882H transcripts in patients with acute myeloid leukemia. American Journal of Hematology 2018; 93(5):E120-E123

 

Patkar N, Kodgule R, Kakirde C, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Hasan SK et. al. Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia. Oncotarget 2018 ; 9(93):36613-36624

 

Salunkhe S, Mishra SV, Nair J, Ghosh S, Choudhary N, Kaur E, Shah S, Patkar K, Anand D, Khattry N, Hasan SK, Dutt S. Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia. International Journal of Cancer. 2018;142:2175-2185

 

Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S, Tembhare P, Hasan SK, Jain H, Sengar M, Narula G, Banavali S, Kadam PA, Shetty D, Gujral S, Patkar N.Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India. Mediterr J Hematol Infect Dis. 2018 1;10(1):e2018002

 

Khattry N, Laskar S, Sengar M et. al. Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit. Indian Journal of Cancer 2018; 55(1):9-15.

 

Siddiqui MQ, Rajpurohit YS, Thapa PS, Maurya GK, Banerjee K, Khan MA, Panda P, Hasan SK, Gadewal N, Misra HS, Varma AK.Studies of protein-protein interactions in Fanconi anemia pathway to unravel the DNA interstrand crosslink repair mechanism. Int J Biol Macromol. 2017;104:1338-1344

 

Siddiqui MQ, Choudhary RK, Thapa P, Kulkarni N, Rajpurohit YS, Misra HS, Gadewal N, Kumar S, Hasan SK*, Varma AK. Structural and biophysical properties of h-FANCI ARM repeat protein. J Biomol Struct Dyn 2017;35:3032-3042 (*co-corresponding author)

 

Bodini M, Ronchini C, Giacò L, Russo A, Melloni GE, Luzi L, Sardella D, Volorio S, Hasan SK et.al. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. Blood 2015;125(4):600-5

 

Mancini M, Hasan SK, Ottone T et. al. Two novel methods for the rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia. Journal of Molecular Diagnositics 2015; 17(2):179-84

 

Hasan SK, Barba G, Metzler M et. al. Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t (4; 11) (q21; q23). Genes Chromosomes Cancer 2014; 53 (3): 248-54

 

Ottone T*, Hasan SK*, Voso MT et. al. Genomic analysis of acute therapy-related promyelocytic leukemias arising after malignant and non-malignant disorders. American Journal of Hematology 2014; 89 (3): 346-7 (*Joint first authors)

 

Lo-Coco F, Hasan SK. Understanding the molecular pathogenesis of acute promyelocytic leukemia. Best Practice & Research in Clinical Haematology 2014; 27 (1): 3-9

 

Ottone T, Zaza S, Divona M, Hasan SK et. al. Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukemia with mutated nucleophosmin. British Journal of Haematology 2013; 161 (4): 533-40

 

Ashraf S, Noguera NI, J Di Giandomenico, Zaza S, Hasan SK , Lo-Coco F. Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia. Annals of Hematology 2013; 92 (10): 1319-23

​

Lo-Coco F , Hasan SK, Montesinos P and Sanz MA. Biology and management of acute therapy-related promyelocytic leukemia. Current  Opinion in  Oncology 2013; 25 (6): 695-700

​

Ottone T, L Cicconi, Hasan SK et. al. Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia. Leukemia Research 2012; 36 (4): 474-8 (IF 2.3)

​

Ramadan SM, TM Fouad, Summa V, Hasan SK, Lo-Coco F. Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica 2012; 97 (6): 805-17

​

Ammatuna E, P Montesinos, Hasan SK. Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis. Haematologica 2011; 96 (4): 621-5

 

Hasan SK, Buttari F, Ottone T et. al. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology 2011; 76 (12): 1059-65

 

Mays AN, Osheroff N, Xiao Y, Wiemels JL, Felix CA, Byl JA, Saravanamuttu K, Peniket A, Corser R, Chang C, Hoyle C, Parker AN, Hasan SK, et. al. Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t (15; 17) therapy-related acute promyelocytic leukemia. Blood 2010, 115(2):326-30

 

Hasan SK, Ottone T, Schlenk RF et. al. Analysis of t (15; 17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. Genes Chromosomes Cancer 2010; 49(8):726-32

 

Hasan SK, Lo-Coco F. Utilization of molecular phenotypes to detect relapse and optimize the management of acute promyelocytic leukemia. Clinical Lymphoma Myeloma and Leukemia 2010

 

37) Ottone T, Hasan SK, Montefusco E et. al. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t (16; 21) translocation. Genes Chromosomes Cancer 2009; 48(3):213-21

 

38) Hasan SK, Mays AN, Ottone T et. al. Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis. Blood 2008;112:3383-90

 

Sazawal S, Kumar B, Hasan SK, Dutta P, Kumar R, Chaubey R, Mir R, Saxena R. Haematological & molecular profile of acute myelogenous leukaemia in India. Indian J Med Res 2008;129:256-61

 

Dutta P, Hasan SK, Sazawal S, Kumar B, Bhattacharyya J, Jain M, Tyagi S, Kumar R, Pati HP, Saxena R. AML1-ETO positive AML: first report from India. Indian J Pathol Microbiol 2007;50:652-4.

 

Hasan SK, Sazawal S, Dutta P, Pillai LS, Kumar B, Chaubey R, Kumar R, Saxena R. Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: prognostic implications. Hematology 2007;12:99-101.

 

Sazawal S, Hasan SK, Kumar B, Kumar R, Kumar L, Saxena R. Timing of allogeneic BMT for CML patients in India: does it affect response? Am J Hematol 2007;82:329

 

Hasan SK, Sazawal S, Kumar B, Chaubey R, Mishra P, Mir R, Chaudhry VP, Saxena R. Childhood CML in India: b2a2 transcript is more common than b3a2. Cancer Genet Cytogenet. 2006;169:76-7.

​

Dutta P, Hasan SK, Bhattacharyya J, Kumar R, Mahapatra M, Saxena R, Tyagi S, Sazawal S, Pati HP. Acute promyelocytic leukemia with secondary myelofibrosis-case report and review of the literature. Am J Hematol 2006;81:476-7

 

Sazawal S, Hasan SK, Dutta P, Kumar B, Kumar R, Kumar L, Choudhry VP, Saxena R. Over-representation of bcr3 subtype of PML/RARalpha fusion gene in APL in Indian patients. Ann Hematol 2005;84:781-4